NCT03644394

Brief Summary

The Implantable Myoelectric Sensors (IMES) system is an investigational device intended to improve signal quality and consistency of myoelectric signals for prosthetic control in individuals suffering from an above elbow (transhumeral) amputation. The sensors pick up myoelectric signals intramuscularly and therefore signal quality is not affected from electrode replacement, perspiration, or artefacts.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2014

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2014

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2017

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

August 11, 2018

Completed
12 days until next milestone

First Posted

Study publicly available on registry

August 23, 2018

Completed
Last Updated

August 23, 2018

Status Verified

August 1, 2018

Enrollment Period

3.2 years

First QC Date

August 11, 2018

Last Update Submit

August 21, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in hand function over time

    Southampton Hand Assessment Procedure

    at 3, 6, 9 and 12 months after final prosthetic fitting

Study Arms (1)

Implantation

OTHER

Surgical Implantation of IMES sensors

Device: Implantation of IMES sensors

Interventions

Surgical implantation of IMES sensors during routine surgery to improve prosthetic control

Implantation

Eligibility Criteria

Age16 Years - 70 Years
Sexmale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • unilateral transhumeral amputation
  • can speak and comprehend German
  • undergone amputee rehabilitation, including being trained to wear and use a conventional myoelectric prosthesis
  • residual upper limb meets the criterions for TMR surgery

You may not qualify if:

  • Known genetic neuromuscular disorder
  • bleeding or clotting disorder
  • active implant
  • any metal fragments or metal implants located within the residual upper limb stump
  • Female patients if pregnant or breast-feeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Christian Hofer, PhD

    Otto Bock

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Subinvestigator

Study Record Dates

First Submitted

August 11, 2018

First Posted

August 23, 2018

Study Start

August 1, 2014

Primary Completion

October 1, 2017

Study Completion

October 1, 2017

Last Updated

August 23, 2018

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will not share

The study including all results is already submitted to be published